MAZE
Maze Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.52
−3.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 168.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.76x
- Price / sales
- 62.55x
- Price / cash flow
- -11.74x
Enterprise value
- Enterprise value
- $900.3M
- EV / sales
- 45.02x
- EV / EBITDA
- -6.91x
- EV / EBIT
- -6.18x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026